<DOC>
	<DOCNO>NCT02912234</DOCNO>
	<brief_summary>This study evaluate effect multiple-dose clarithromycin single-dose pharmacokinetics ( PK ) apixaban parameter like Cmax , AUC ( INF ) , AUC ( 0-T ) .</brief_summary>
	<brief_title>Effect Clarithromycin Pharmacokinetics Apixaban Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<criteria>1 . Signed Informed Consent 2 . Target population : Healthy subject determine medical history , surgical history , physical examination , vital sign , electrocardiogram ( ECG ) , clinical laboratory test include coagulation parameter . 3 . Subjects body mass index 18 30 kg/m2 , inclusive 4 . Women must breast feeding , negative serum urine pregnancy test must agree follow instruction method ( ) contraception duration treatment study treatment apixaban clarithromycin plus 5 halflives study treatment apixaban clarithromycin plus 30 day ( duration ovulatory cycle ) total 33 day posttreatment completion . 5 . Men sexually active WOCBP must agree follow instruction method ( ) contraception duration treatment study treatment apixaban clarithromycin plus 5 halflives study treatment plus 30 day total 33 day posttreatment completion . In addition , male participant must willing refrain sperm donation time . 1 . History significant medical illness , drug allergy include allergy apixaban , FXa inhibitor ( and/or excipients ) , clarithromycin , macrolides , and/or related compound . History substance abuse use nicotine containing product and/or alcohol abuse . 2 . History coagulopathy , prolong unexplained clinically significant bleeding , frequent unexplained bruising thrombus formation , include hypermenorrhea , intracranial hemorrhage , family history bleed disorder first degree relative , and/or adverse reaction anticoagulant antiplatelet agent result excessive bleeding . 3 . History recurrent neurological gastrointestinal disorder , include insomnia , chronic headache , dizziness , gastroesophageal reflux disease , cholecystectomy , gastric ulcer and/or Gilbert 's syndrome . 4 . History antibiotic induce secondary infection , include candidiasis . 5 . Evidence organ dysfunction clinically significant deviation normal physical examination , vital sign , ECG , clinical laboratory test beyond consistent target population .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>